ERBB2 and breast cancer: Hwang et al. showed that Bcl-2 expression was different according to the molecular subtypes of breast cancer and upregulated in the luminal A and luminal B subtypes compared to the HER2 and basal-like subtypes [25], which is consistent with our results.